Curcumin-Based Therapeutics in Periodontal Disease Management

Curcumin, a bioactive polyphenol derived from turmeric, has emerged as a multifaceted adjunct in the management of periodontal disease. Its anti-inflammatory and antioxidant properties attenuate key mediators of tissue destruction, notably nuclear factor-κB (NF-κB) and reactive oxygen species, while antimicrobial effects disrupt subgingival biofilms. Chemical modification and advanced delivery platforms—such as triketonic curcumin derivatives and nanoparticle systems—overcome issues of poor solubility and rapid metabolism, enabling sustained release within periodontal pockets. By inhibiting matrix metalloproteinases and osteoclastogenesis, and by promoting a shift from pro-inflammatory to pro-resolving macrophage phenotypes, curcumin-based formulations support both the arrest of disease progression and the regeneration of supporting tissues. These innovations offer a host-modulatory strategy that complements conventional debridement and reduces reliance on systemic antibiotics.

Research from Nature Portfolio

A novel chemically modified curcumin derivative, CMC2.24, has been shown to normalise excessive matrix metalloproteinase-9 secretion in macrophages exposed to bacterial lipopolysaccharide and advanced glycation end-products. Importantly, treatment with CMC2.24 elevated resolvin D1 and soluble receptor for AGE levels, and induced a clear shift from a pro-inflammatory M1 to a pro-resolving M2 macrophage phenotype, suggesting a potent host-modulatory “switch” that accelerates resolution of inflammation. In a separate study, local injection of curcumin-loaded nanoparticles directly into gingival tissues completely inhibited inflammatory bone resorption and reduced osteoclast counts in an experimental periodontitis model. These nanoparticles attenuated p38 MAPK and NF-κB activation, diminished inflammatory infiltrate and preserved alveolar bone architecture, demonstrating the effectiveness of site-specific curcumin delivery in controlling periodontal inflammation and tissue loss.

Curcumin-Based Therapeutics in Periodontal Disease Management publication trend

The graph below shows the total number of articles in curcumin-based therapeutics in periodontal disease management across all publications each year (not limited to Nature Index journals).

Technical terms

Ferroptosis: A regulated form of cell death driven by iron-dependent lipid peroxidation, distinct from apoptosis and necrosis.

Matrix metalloproteinases (MMPs): A family of zinc-dependent enzymes that degrade extracellular matrix components and contribute to tissue destruction.

Nuclear factor-κB (NF-κB): A transcription factor central to the regulation of inflammatory gene expression and immune response.

Macrophage phenotypes (M1/M2): Functional states of macrophages, where M1 is pro-inflammatory and M2 is pro-resolving and reparative.

Resolvin: Endogenous lipid mediators derived from fatty acids that orchestrate the resolution phase of inflammation.

References

1. Curcumin Attenuates Periodontal Injury via Inhibiting Ferroptosis of Ligature-Induced Periodontitis in Mice. International Journal of Molecular Sciences (2023).
2. Effect of Curcumin gel on inflammatory and anti-inflammatory biomarkers in experimental induced periodontitis in rats: a biochemical and immunological study. Frontiers in Microbiology (2023).
3. A novel modified-curcumin 2.24 resolves inflammation by promoting M2 macrophage polarization. Scientific Reports (2023).
4. Local administration of curcumin-loaded nanoparticles effectively inhibits inflammation and bone resorption associated with experimental periodontal disease. Scientific Reports (2018).